INNOCAN PHARMA Corp (INNP, INNPF)

CIK 1889791 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for INNOCAN PHARMA Corp.

Recent SEC filings

FiledFormAccession number
Apr 3, 2026FWP0001493152-26-015156
Apr 3, 2026F-1/A0001493152-26-015152
Mar 16, 2026F-10001493152-26-010255
Mar 16, 2026FWP0001493152-26-010291
Feb 23, 2026RW0001493152-26-007688
Jan 30, 2026EFFECT9999999995-26-000367
Jan 7, 2026F-1/A0001493152-26-000726
Jan 6, 2026FWP0001493152-26-000541
Jan 6, 2026F-1/A0001493152-26-000539
Dec 22, 20258-A12B/A0001493152-25-028784
Dec 19, 20258-A12B/A0001493152-25-028448
Dec 16, 20258-A12B/A0001493152-25-027960
Dec 10, 2025F-1/A0001493152-25-027017
Dec 10, 2025FWP0001493152-25-027063
Oct 22, 2025F-1/A0001493152-25-018908
Oct 1, 2025FWP0001493152-25-016465
Sep 30, 2025F-1/A0001493152-25-016393
Sep 22, 20258-A12B0001493152-25-014469
Sep 12, 2025FWP0001493152-25-013131
Sep 5, 2025F-1/A0001493152-25-012688
Sep 5, 2025FWP0001493152-25-012694
Aug 4, 2025F-1/A0001493152-25-011564
Jul 23, 2025F-10001641172-25-020718
Oct 26, 2021D0001213900-21-054585